Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment
AssigneeNovosis Pharma AG
InventorsWilfried Fischer, Axel Stierle
Life of this patent
Estimating the term…
Abstract
This invention refers to a transdermal system for release of 5-HT3 receptor antagonists which is characterized in that it contains a composition of a 5-HT3 receptor antagonist as an active agent, tea tree oil, a water-miscible solvent and water.
Claims21
Transdermal system for release of 5-HT3 receptor antagonists comprising a composition comprising a 5-HT3 receptor antagonist as an active agent, tea tree oil, ethand and water.
A method of treating nausea and/or emesis using a transdermal system comprising a composition comprising a 5-HT3 receptor antagonist as an active agent, tea tree oil, ethanol and water is applied to the skin and delivers the active agent to the body.
Dependencies are inferred from the claim text.